Northern Trust Corp Arrowhead Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,332,765 shares of ARWR stock, worth $26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,332,765

Previous 1,322,718 0.76%

Holding current value

$26 Million

Previous $34.4 Million 24.94%

% of portfolio

0.0%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$19.36 - $29.54 $194,509 - $296,788	10,047 Added 0.76%	1,332,765 $25.8 Million
Q2 2024 Aug 14, 2024	BUY	$21.87 - $28.24 $482,649 - $623,228	22,069 Added 1.7%	1,322,718 $34.4 Million
Q1 2024 May 14, 2024	BUY	$27.21 - $39.48 $1.93 Million - $2.8 Million	71,034 Added 5.78%	1,300,649 $37.2 Million
Q4 2023 Feb 13, 2024	SELL	$21.2 - $31.03 $784,103 - $1.15 Million	-36,986 Reduced 2.92%	1,229,615 $37.6 Million
Q3 2023 Nov 13, 2023	SELL	$26.2 - $36.08 $830,068 - $1.14 Million	-31,682 Reduced 2.44%	1,266,601 $34 Million
Q2 2023 Aug 11, 2023	SELL	$25.16 - $41.38 $546,198 - $898,318	-21,709 Reduced 1.64%	1,298,283 $46.3 Million
Q1 2023 May 15, 2023	BUY	$23.68 - $38.51 $857,026 - $1.39 Million	36,192 Added 2.82%	1,319,992 $33.5 Million
Q4 2022 Feb 13, 2023	BUY	$28.0 - $40.56 $132,832 - $192,416	4,744 Added 0.37%	1,283,800 $52.1 Million
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $506,287 - $825,472	-17,087 Reduced 1.32%	1,279,056 $42.3 Million
Q2 2022 Aug 12, 2022	SELL	$27.79 - $50.61 $2.48 Million - $4.52 Million	-89,251 Reduced 6.44%	1,296,143 $45.6 Million
Q1 2022 May 13, 2022	SELL	$39.62 - $69.97 $1.46 Million - $2.57 Million	-36,755 Reduced 2.58%	1,385,394 $63.7 Million
Q4 2021 Feb 08, 2022	SELL	$58.09 - $82.51 $1.27 Million - $1.8 Million	-21,802 Reduced 1.51%	1,422,149 $94.3 Million
Q3 2021 Nov 15, 2021	SELL	$58.38 - $84.96 $2.75 Million - $4 Million	-47,087 Reduced 3.16%	1,443,951 $90.1 Million
Q2 2021 Aug 13, 2021	SELL	$62.15 - $90.32 $3.42 Million - $4.97 Million	-55,030 Reduced 3.56%	1,491,038 $123 Million
Q1 2021 May 12, 2021	SELL	$61.35 - $90.47 $758,101 - $1.12 Million	-12,357 Reduced 0.79%	1,546,068 $103 Million
Q4 2020 Feb 11, 2021	SELL	$43.82 - $85.37 $1.62 Million - $3.15 Million	-36,883 Reduced 2.31%	1,558,425 $120 Million
Q3 2020 Nov 16, 2020	SELL	$33.21 - $51.27 $2.97 Million - $4.59 Million	-89,454 Reduced 5.31%	1,595,308 $68.7 Million
Q2 2020 Aug 14, 2020	BUY	$26.12 - $43.27 $1.71 Million - $2.84 Million	65,577 Added 4.05%	1,684,762 $72.8 Million
Q1 2020 May 14, 2020	BUY	$20.56 - $63.12 $1.37 Million - $4.2 Million	66,478 Added 4.28%	1,619,185 $46.6 Million
Q4 2019 Feb 14, 2020	BUY	$28.14 - $73.01 $7.55 Million - $19.6 Million	268,371 Added 20.9%	1,552,707 $98.5 Million
Q3 2019 Nov 13, 2019	BUY	$26.26 - $34.86 $712,591 - $945,960	27,136 Added 2.16%	1,284,336 $36.2 Million
Q2 2019 Aug 13, 2019	BUY	$17.43 - $28.82 $1.07 Million - $1.76 Million	61,133 Added 5.11%	1,257,200 $33.3 Million
Q1 2019 May 13, 2019	BUY	$12.05 - $20.18 $1.3 Million - $2.17 Million	107,755 Added 9.9%	1,196,067 $21.9 Million
Q4 2018 Feb 12, 2019	SELL	$10.74 - $19.7 $225,024 - $412,754	-20,952 Reduced 1.89%	1,088,312 $13.5 Million
Q3 2018 Nov 14, 2018	BUY	$14.0 - $20.3 $640,710 - $929,029	45,765 Added 4.3%	1,109,264 $21.3 Million
Q2 2018 Sep 18, 2018	BUY	$6.37 - $14.02 $215,344 - $473,960	33,806 Added 3.28%	1,063,499 $14.5 Million
Q2 2018 Aug 14, 2018	BUY	$6.37 - $14.02 $5.15 Million - $11.3 Million	808,176 Added 364.84%	1,029,693 $14 Million
Q1 2018 May 09, 2018	BUY	$3.72 - $7.64 $92,747 - $190,480	24,932 Added 12.68%	221,517 $1.6 Million
Q4 2017 Feb 14, 2018	BUY	$3.14 - $4.5 $5,058 - $7,249	1,611 Added 0.83%	196,585 $724,000
Q3 2017 Nov 13, 2017	BUY	$1.69 - $4.33 $329,506 - $844,237	194,974	194,974 $844,000

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.07B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Arrowhead Pharmaceuticals, Inc. Transaction History